Literature DB >> 27810338

Esculetin: A phytochemical endeavor fortifying effect against non-communicable diseases.

Almesh Kadakol1, Nisha Sharma1, Yogesh Anant Kulkarni2, Anil Bhanudas Gaikwad3.   

Abstract

Esculetin, a naturally occurring 6,7-dihydroxy derivative of coumarin has shown its potential role in various non-communicable diseases (NCDs) including obesity, diabetes, cardiovascular, renal failure, cancer and neurological disorders. NCDs, responsible for about 70% of the deaths occurring globally are majorly attributed to tobacco or alcohol abuse, sedentary lifestyle, and unhealthy diets. It can be managed by improving access to cost-effective treatment, care and prevention. The beneficial effects of esculetin in NCDs have been ascribed to its antioxidant, anti-proliferative and cytoprotective potential. This review attempts to summarize the beneficial effects shown by the emerging molecule and the underlying mechanisms. This may help us in improving our understanding of the molecule and may encourage the researchers to ponder over further development of esculetin as a potential therapeutic intervention in NCDs.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-oxidant; Coumarins; Epigenetics; Esculetin; Non-communicable diseases

Mesh:

Substances:

Year:  2016        PMID: 27810338     DOI: 10.1016/j.biopha.2016.10.072

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Behavioral, neuroplasticity and metabolic effects of 7,8-dihydroxy-4-methylcoumarin associated with physical activity in mice.

Authors:  Priscilla Karla Fernandes Lopes; Daiane Fátima Engel; Natalia Oliveira Bertolini; Moisés Silvestre de Azevedo Martins; Chrystian Araujo Pereira; Licio Augusto Velloso; Sérgio Scherrer Thomasi; Rodrigo Ferreira de Moura
Journal:  Metab Brain Dis       Date:  2021-10-02       Impact factor: 3.584

Review 2.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

3.  Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle.

Authors:  Kader Turkekul; R Dilsu Colpan; Talha Baykul; Mehmet D Ozdemir; Suat Erdogan
Journal:  J Cancer Prev       Date:  2018-03-30

4.  Multiple-Purpose Connectivity Map Analysis Reveals the Benefits of Esculetin to Hyperuricemia and Renal Fibrosis.

Authors:  Yiming Wang; Weikaixin Kong; Liang Wang; Tianyu Zhang; Boyue Huang; Jia Meng; Baoxue Yang; Zhengwei Xie; Hong Zhou
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

Review 5.  Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer's Disease Dementia.

Authors:  Wataru Araki; Fuyuki Kametani
Journal:  Antioxidants (Basel)       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.